Confidential listings
Your name, your staff, and your numbers stay private. Buyers see what they need to make an offer — and only after they sign.
A discreet marketplace for buying and selling independent pharmacies.
Confidential introductions between qualified buyers and owners ready for transition. Built for how pharmacy deals actually close — not how marketplaces usually run.
Confidential by design
Process built for how pharmacy deals actually close
Active CT portfolio under engagement
For Sellers
A quiet, dignified exit — without putting your business on a public marketplace.
You spent decades building this. The transition deserves the same care. We bring you a vetted shortlist of buyers, under NDA, before anything is on paper.
Pre-qualified buyers
Operators, regional groups, and family offices we already know. No tire-kickers, no "exploring options" emails.
Fair valuation
Multiples grounded in pharmacy-specific comps — script counts, payor mix, DIR exposure, working-capital peg — not generic small-business rules of thumb.
For Buyers
Deal flow that doesn’t show up on open marketplaces.
Operators, regional groups, and family offices come to us for retail-pharmacy opportunities with established top-line, existing operating teams, and clear margin-improvement levers.
Vetted opportunities
Each engagement comes with a confidential overview — financials, scripts, payor mix, real-estate footprint — packaged the way diligence actually wants it.
Built for how the deal closes
NDA, indication of interest, management diligence, definitive agreement. Predictable steps, predictable cadence, no theatrics.
Pharmacy-native diligence support
PBM concentration, DIR exposure, working-capital peg, cash-free / debt-free — the questions a pharmacy deal actually turns on, surfaced early.
How It Works
A predictable path from introduction to closing.
The same four-step process used by institutional pharmacy buyers and sellers — adapted for owner-operators. No mystery, no surprises.
-
01
Sign NDA
A short, mutual confidentiality agreement before any names or numbers are shared.
-
02
Submit IOI
An indication of interest at a workable range. We screen for fit before either side spends real time.
-
03
Management Diligence
Operations, payor mix, working capital, and people questions answered the way an acquirer needs them.
-
04
Definitive Agreement
Terms locked, transition planned, and the deal closes on a calendar both sides have signed off on.
Why Now
Independent pharmacy is in the middle of a generational handoff.
Owner-operators who built their stores in the 80s and 90s are deciding what comes next, often on a compressed timeline. Reimbursement pressure from the major PBMs and DIR clawbacks have made margin engineering more technical than it has ever been. And buyers — regional consolidators, family offices, and well-capitalized operators — are looking for retail pharmacy with established top-line and a real operating team.
The mismatch is rarely capital. It is introduction, fit, and process. We exist for that gap.
In Their Own Words
“We didn’t want our pharmacy on a website with a price tag on it. The introductions came quietly, the buyer was already serious, and our staff didn’t hear about it until we wanted them to.”
Owner, redacted CT pharmacy portfolio
Frequently Asked
Questions owners and buyers ask before they reach out.
How is confidentiality protected?
Nothing about a seller — name, brand, location, financials, or staff — is shared until a prospective buyer signs a mutual NDA. Buyers see a confidential overview, not a public listing.
How do you make money?
Standard sell-side success-fee model on closing. There is no fee to the seller for being listed and no subscription for buyers to receive opportunities. Specifics are confirmed in writing before any engagement.
Who runs RX Buy Sell?
A small team with a background in middle-market M&A and pharmacy operations. We focus exclusively on independent retail pharmacy and small portfolio transactions.
How are listings vetted?
Each opportunity goes through a structured intake: financial review, payor-mix analysis, working-capital position, real-estate footprint, and a quick read on PBM and DIR exposure. We don’t take everything that comes through the door.
How long does a typical transaction take?
From signed engagement to closing, three to seven months is typical for a single-store deal, longer for portfolios. Diligence is the variable — clean books and a clear ownership structure can compress the timeline considerably.
Can I be both a buyer and a seller?
Yes. Many of our buyers are operators who eventually become sellers, and vice versa. The two sides aren’t mutually exclusive.
A discreet marketplace for independent pharmacies.
Launching soon.